SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Therapeutic Advances in Cardiovascular Disease
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sonoyama, K.
Right arrow Articles by Heagerty, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sonoyama, K.
Right arrow Articles by Heagerty, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Reviews

Review: Vascular remodeling: implications for small artery function and target organ damage

Kazuhiko Sonoyama

Cardiovascular Research Group, Division of Cardiovascular and Endocrine Sciences, University of Manchester, United Kingdom

Adam Greenstein

Cardiovascular Research Group, Division of Cardiovascular and Endocrine Sciences, University of Manchester, United Kingdom, Wellcome Trust Clinical Research Facility, Manchester Royal Infirmary, Manchester, United Kingdom

Anna Price

Cardiovascular Research Group, Division of Cardiovascular and Endocrine Sciences, University of Manchester, United Kingdom

Kaivan Khavandi

Cardiovascular Research Group, Division of Cardiovascular and Endocrine Sciences, University of Manchester, United Kingdom

Tony Heagerty

Cardiovascular Research Group, Division of Cardiovascular and Endocrine Sciences, University of Manchester, United Kingdom, Wellcome Trust Clinical Research Facility, Manchester Royal Infirmary, Manchester, United Kingdom, tony.heagerty@ manchester.ac.uk

At the level of the small artery, essential hypertension is associated with eutrophic inward remodeling. This involves reduction in lumen diameter by an increase in wall thickness. Previously thought to involve either hypertrophy or hyperplasia of the vascular smooth muscle cells in the media, it is now felt to be mediated by a functional property of the wall: myogenic tone. This is the ability of an artery to contract in response to an increase in intraluminal pressure. This autoregulatory function is also vital to ensure stabilisation of distal capillary pressures and so prevent, or limit, organ damage. Indeed in any animal model studied, when myogenic autoregulation is affected, target organ damage ensues. We have also observed, in two studies, that when myogenic autoregulation is damaged in the context of hypertension, eutrophic remodeling is replaced by an outward growth of the arterial wall with preservation of lumen diameter. This is called hypertrophic remodeling and, independently, has been observed by a number of groups in small arteries from patients with type 2 diabetes. We believe that this is a key reason for the unique propensity to hypertensive injury seen in patients with diabetes. We also discuss the significance of integrins, transmembrane proteins with wide ranging functions; from initiation of cell migration to intracellular signalling. Two particular integrins, {alpha}5β1 and {alpha}{nu}β3, have been found to be necessary for both normal myogenic autoregulation and eutrophic remodeling and the possibility that damage to these may occur in diabetes is examined.

Key Words: hypertension • small artery • diabetes • target organ damage • eutrophic remodeling • hypertrophic remodeling • myogenic tone

Therapeutic Advances in Cardiovascular Disease, Vol. 1, No. 2, 129-137 (2007)
DOI: 10.1177/1753944707086358


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




Advertisement